IJMS Cover Letter: What Editors Actually Need to See
IJMS academic editors screen for scope fit, methodological completeness, and MDPI compliance items before anything else.
Readiness scan
Before you submit to International Journal of Molecular Sciences, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
International Journal of Molecular Sciences at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- International Journal of Molecular Sciences's scope and readership determine whether the journal is a useful target.
- Scope specificity matters more than headline metrics for most manuscript decisions.
- Manusights does not list an acceptance rate for International Journal of Molecular Sciences.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
- If timeline matters: International Journal of Molecular Sciences takes 17.5 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs CHF 2900. Check institutional agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Getting the structure, tone, and decision logic right before you send anything out. |
Most important move | Make the reviewer-facing or editor-facing ask obvious early rather than burying it in prose. |
Common mistake | Turning a practical page into a long explanation instead of a working template or checklist. |
Next step | Use the page as a tool, then adjust it to the exact manuscript and journal situation. |
Quick answer: a strong International Journal of Molecular Sciences cover letter proves compliance completeness and molecular-level scope fit.
With an IF of 5.6 and a rejection rate that MDPI lists at 61% for 2025 and 57% for 2026 (data as of 30 June 2026), the academic editors screen for whether your submission package is ready for review, not whether the finding will change the field.
What IJMS Editors Screen For
Criterion | What They Want | Common Mistake |
|---|---|---|
Molecular scope fit | A molecular sciences component in the research | Submitting work without a molecular-level dimension |
Data availability statement | Mandatory statement specifying where data can be accessed | Missing data availability statement, which MDPI makes mandatory for research articles |
Ethics documentation | IRB/IACUC protocol numbers included when applicable | Missing ethics statements without specific protocol numbers |
Methodology completeness | Methods section detailed enough for reproducibility | Incomplete methodology sections that trigger desk rejection |
Compliance readiness | Submission package complete and MDPI-compliant from the start | Missing mandatory MDPI items that delay the fast editorial timeline |
What the official sources do and do not tell you
MDPI's author instructions list formatting requirements, the MDPI SuSy submission system submission system, and mandatory items like data availability statements and ethics approvals. What they do not emphasize is that the cover letter at IJMS functions more as a compliance document than a persuasion exercise.
IJMS editorial decisions are made by Academic Editors, not MDPI staff. These are working scientists handling manuscripts in their area. They process enormous volume: MDPI's statistics page lists 115,039 papers published since 2000. Your letter will be read in under two minutes. The editor is not deciding whether your paper will change the field. They are confirming scope fit, checking that mandatory items are present, and verifying there is enough methodological detail to send the paper to reviewers.
MDPI publishes no desk-rejection rate, and missing compliance items are a separate category that delays your timeline. MDPI's technical pre-check checks adherence to the Instructions for Authors, and manuscripts that fail it to the extent that further review is prevented do not proceed to review. A missing data availability statement or an ethics approval without a project identification code can stop a manuscript there.
What the editor is really screening for
At triage, the editor is usually asking:
- Does this paper have a molecular sciences component, or is it purely clinical, epidemiological, or materials-focused?
- Is the data availability statement present, with repository accession numbers if applicable?
- Are ethics approvals complete with committee names and protocol numbers, not just boilerplate?
- Are cell line authentication, antibody validation, and statistical methods documented?
A cover letter that answers the first question in the opening paragraph will survive triage.
A practical template you can adapt
Dear Editor,
We submit the manuscript "the manuscript title" for consideration as a
research article in the International Journal of Molecular
Sciences.
sTATE THE MOLECULAR QUESTION AND FINDING IN 2-3 SENTENCES. Example: "Using CRISPR-Cas9 screening in patient-derived glioblastoma organoids, we identified PTBP1 as a regulator of temozolomide resistance through alternative splicing of the MGMT transcript."
[CONFIRM METHODS AND DATA. Example: "Experiments include
biological triplicates with nonlinear regression analysis.
RNA-seq data are deposited in GEO under accession GSE######."]
We confirm: all data are described in the Data Availability
Statement; [ethics approval from COMMITTEE, protocol NUMBER];
cell lines authenticated by STR profiling and mycoplasma-
tested; no conflicts of interest. Neither the manuscript nor any
parts of its content are currently under consideration for
publication with or published in another journal. All authors
have approved the manuscript and agree with its submission to IJMS.
Sincerely,
Corresponding authorThe compliance confirmation block is the element that matters most at this journal.
Mistakes that make these letters weak
- Missing the data availability statement, which MDPI makes mandatory for research articles
- Submitting a clinical-outcomes or epidemiology paper with no molecular-level data, which belongs in Journal of Clinical Medicine or Pharmaceuticals
- Writing generic ethics statements ("conducted in accordance with ethical standards") instead of naming the committee and protocol number
- Recycling a cover letter from a high-selectivity journal with paragraphs arguing for broad impact, which signals you have not adjusted for the MDPI system
- Forgetting cell line authentication details (STR profiling, mycoplasma testing); IJMS's instructions say Methods sections should state the origin of any cell lines
What should drive the submission decision instead
Before polishing the cover letter, verify that the paper has a genuine molecular-sciences component. A pharmacological study measuring only clinical endpoints belongs in a different MDPI journal. Review the IJMS author instructions and confirm that every mandatory compliance item is present in the manuscript before uploading to MDPI SuSy submission system.
Practical verdict
Missing compliance items can stop a manuscript at MDPI's technical pre-check before an Academic Editor sees it. The cover letter's job is to confirm everything is in order.
So the useful takeaway is this: state the molecular question, confirm data availability and ethics approvals with specific details, and keep the letter under one page. A IJMS cover letter framing check is a direct way to pressure-test whether your framing already does that before submission.
What we see in IJMS submissions
For manuscripts targeting International Journal of Molecular Sciences, the cover-letter problem is usually not persuasiveness. It is operational readiness. IJMS editors are often deciding whether the manuscript is review-ready from a compliance and scope standpoint in a very short first pass.
The first recurring failure is treating the cover letter like a prestige-journal sales pitch. That rarely helps here. Editors want to know the molecular question, whether the paper belongs in the journal, and whether the package is complete enough to move forward without a return for missing items.
The second failure is not surfacing compliance details cleanly enough. If the data availability statement, repository location, ethics protocol, or cell-line validation is easy to miss, the submission starts to look operationally messy even when the manuscript itself is sound.
The third failure is using IJMS for papers with only a weak molecular dimension. Clinical, epidemiologic, or materials papers can all mention molecular concepts without actually being molecular-sciences papers. The letter needs to show that the molecular component is central, not decorative.
A IJMS cover letter framing check is a direct way to test whether the manuscript looks both scope-fit and submission-ready before uploading.
Submit If / Think Twice If
Submit if:
- the manuscript has a clear molecular-sciences question rather than only a clinical or descriptive outcome
- the cover letter can confirm data availability, ethics, and key compliance items cleanly
- the paper is operationally ready for MDPI's fast editorial workflow
- the molecular component is central enough that removing it would break the paper's main contribution
Think twice if:
- the manuscript is mainly clinical, epidemiologic, or materials-focused with only a thin molecular layer
- the data availability or ethics documentation is still incomplete
- the cover letter still reads like a broad-impact pitch rather than a compliance-and-scope confirmation
- you are relying on the cover letter to compensate for a manuscript package that is not actually ready
Readiness check
Run the scan while International Journal of Molecular Sciences's requirements are in front of you.
See how this manuscript scores against International Journal of Molecular Sciences's requirements before you submit.
MDPI cover letter requirements
MDPI journals use a rapid review model with mandatory open access. Keep the cover letter concise. IJMS's instructions ask the cover letter to explain why the content of the paper is significant, place the findings in the context of existing work, and explain why the manuscript fits the scope of the journal, and they require two confirmation statements (not under consideration or published elsewhere, and all authors approved the submission to IJMS).
A IJMS cover letter and desk-rejection risk check scores fit against the journal's editorial bar.
Before you submit
A IJMS cover letter and submission readiness check identifies the specific framing issues that trigger desk rejection before you submit.
Additional MDPI cover letter requirements
MDPI journals use a rapid review model with mandatory open access. Keep the cover letter concise. IJMS's instructions ask the cover letter to explain why the content of the paper is significant, place the findings in the context of existing work, and explain why the manuscript fits the scope of the journal, and they require two confirmation statements (not under consideration or published elsewhere, and all authors approved the submission to IJMS).
A IJMS cover letter and desk-rejection risk check scores fit against the journal's editorial bar.
Frequently asked questions
MDPI's journal statistics page lists a rejection rate of 61% for 2025 and 57% for 2026 (data as of 30 June 2026). MDPI does not publish a desk-rejection rate, but missing compliance items (data availability statement, ethics approval numbers) can stop a manuscript at the technical pre-check and delay your timeline.
Yes. A data availability statement is mandatory at IJMS for research articles. You must specify where data can be accessed: public repositories, supplementary materials, or available upon request, and a statement is still required where no new data were created or the data cannot be shared.
IJMS is one of the fastest journals in molecular sciences. MDPI reports a median of approximately 17.5 days from submission to first decision (median values for papers published in this journal in the first half of 2026), reflecting MDPI streamlined workflow and the high volume of academic editors handling manuscripts.
MDPI's technical pre-check checks adherence to the Instructions for Authors and the ethics policies, and the Academic Editor's pre-check assesses scope fit and scientific soundness. The points to get right before submitting are scope (a molecular sciences component), ethics statements with the ethics committee name and project identification code, a data availability statement, and complete methods.
Sources
Free guide
A cover letter is a routing note, not a sales pitch.
The editor is deciding one thing from it: is this worth my reviewers time, and does it belong here. The guide is a one-page skeleton written to that decision, so the letter answers it in the first minute rather than restating your abstract.
Final step
Submitting to International Journal of Molecular Sciences?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal International Journal of Molecular Sciences
Private API processing. Your manuscript is not used to train models.
See example reportsPut the guidance to work
Move from draft advice to a practical manuscript pass.
Choose the reporting framework first, then use the final checklist when the manuscript and submission files are ready to travel together.
Where to go next
Same journal, next question
- IJMS MDPI Submission Guide: Requirements, Formatting and What Editors Want
- How to Avoid Desk Rejection at International Journal of Molecular Sciences in 2026
- International Journal of Molecular Sciences Review Time 2026: Time to First Decision and Publication
- Is Your Paper Ready for IJMS? Understanding MDPI's Largest Molecular Sciences Journal
- Rejected from International Journal of Molecular Sciences? The 6 Best Journals to Submit Next
- Is International Journal of Molecular Sciences a Good Journal? Fit Verdict